OBJECTIVE: To validate and assess the relationship between self-reported depression as measured by a single item on the Medical Outcomes Study Short-Form 12 (SF-12) and self-reported visual function. METHODS: The Los Angeles Latino Eye Study is population-based and designed to assess the prevalence of visual impairment, ocular disease, and visual functioning in Latinos. Both the 25-item National Eye Institute-Visual Function Questionnaire (NEI VFQ-25) (self-reported visual function) and the SF-12 (health-related quality of life) were administered. A single item from the SF-12 was used to measure self-reported depression and validated against the Center for Epidemiologic Studies-Depression measure of depression. Covariate-adjusted NEI VFQ-25 subscale scores were contrasted across the 6 response choices of the SF-12, as well as across 3 combined response categories of the SF-12 using analysis of covariance. Covariate-adjusted regression analyses assessed the contribution of self-reported depression in explaining self-reported visual function. RESULTS: The sensitivity and specificity of the SF-12 single item with the Center for Epidemiologic Studies-Depression measure was 0.96 and 0.50, respectively. Using the 3 combined response categories of the SF-12 single item, it was found that (1) all covariate-adjusted subscales of the NEI VFQ-25 were statistically significantly different across the self-reported depression categories (P<.001) and (2) covariate-adjusted self-reported depression was a significant predictor of self-reported visual function (P<.001). CONCLUSIONS: A single SF-12 item may be used as a measure of self-reported depression. In addition, self-reported depression is an important covariate to consider when assessing self-reported visual function in Latinos.
OBJECTIVE: To validate and assess the relationship between self-reported depression as measured by a single item on the Medical Outcomes Study Short-Form 12 (SF-12) and self-reported visual function. METHODS: The Los Angeles Latino Eye Study is population-based and designed to assess the prevalence of visual impairment, ocular disease, and visual functioning in Latinos. Both the 25-item National Eye Institute-Visual Function Questionnaire (NEI VFQ-25) (self-reported visual function) and the SF-12 (health-related quality of life) were administered. A single item from the SF-12 was used to measure self-reported depression and validated against the Center for Epidemiologic Studies-Depression measure of depression. Covariate-adjusted NEI VFQ-25 subscale scores were contrasted across the 6 response choices of the SF-12, as well as across 3 combined response categories of the SF-12 using analysis of covariance. Covariate-adjusted regression analyses assessed the contribution of self-reported depression in explaining self-reported visual function. RESULTS: The sensitivity and specificity of the SF-12 single item with the Center for Epidemiologic Studies-Depression measure was 0.96 and 0.50, respectively. Using the 3 combined response categories of the SF-12 single item, it was found that (1) all covariate-adjusted subscales of the NEI VFQ-25 were statistically significantly different across the self-reported depression categories (P<.001) and (2) covariate-adjusted self-reported depression was a significant predictor of self-reported visual function (P<.001). CONCLUSIONS: A single SF-12 item may be used as a measure of self-reported depression. In addition, self-reported depression is an important covariate to consider when assessing self-reported visual function in Latinos.
Authors: Tina M McClure; Dongseok Choi; Kathleen Wooten; Chris Nield; Thomas M Becker; Steven L Mansberger Journal: Am J Ophthalmol Date: 2010-10-16 Impact factor: 5.258
Authors: Xinzhi Zhang; Kai McKeever Bullard; Mary Frances Cotch; M Roy Wilson; Barry W Rovner; Gerald McGwin; Cynthia Owsley; Lawrence Barker; John E Crews; Jinan B Saaddine Journal: JAMA Ophthalmol Date: 2013-05 Impact factor: 7.389
Authors: Yuda Chongpison; Mark C Hornbrook; Robin B Harris; Lisa J Herrinton; Joe K Gerald; Marcia Grant; Joanna E Bulkley; Christopher S Wendel; Robert S Krouse Journal: Psychooncology Date: 2015-09-14 Impact factor: 3.894
Authors: Dominic J Grisafe; Rohit Varma; Bruce S Burkemper; Benjamin Y Xu; Mina Torres; Alicia Fairbrother-Crisp; Cecilia M Patino; Roberta McKean-Cowdin Journal: Am J Ophthalmol Date: 2021-02-08 Impact factor: 5.488
Authors: Christopher G Owen; Alicja R Rudnicka; Liam Smeeth; Jennifer R Evans; Richard P L Wormald; Astrid E Fletcher Journal: BMC Ophthalmol Date: 2006-06-09 Impact factor: 2.209
Authors: G A R Zijlstra; G H M B van Rens; E J A Scherder; D M Brouwer; J van der Velde; P F J Verstraten; G I J M Kempen Journal: BMC Health Serv Res Date: 2009-08-27 Impact factor: 2.655
Authors: Marilita M Moschos; Nikolaos S Gouliopoulos; Chris Kalogeropoulos; Sofia Androudi; George Kitsos; Dimitrios Ladas; Michael Tsatsos; Irini Chatziralli Journal: J Ophthalmol Date: 2018-05-29 Impact factor: 1.909